Uni-Bio Science Group Ltd (UNBSF)
0.004
0.00 (0.00%)
USD |
OTCM |
Dec 13, 16:00
Price Chart
Key Stats
Price and Performance | |
---|---|
Market Cap | 24.07M |
52 Week High (Daily) | Upgrade |
52 Week Low (Daily) | Upgrade |
All-Time High (Daily) | Upgrade |
Year to Date Total Returns (Daily) | Upgrade |
1 Month Total Returns (Daily) | Upgrade |
1 Year Total Returns (Daily) | -- |
Valuation | |
PE Ratio | 1.979 |
PE Ratio (Forward) | Upgrade |
PS Ratio | 0.3852 |
Price to Book Value | 0.6012 |
EV to EBITDA | Upgrade |
Dividend | |
---|---|
Dividend | -- |
Dividend Yield (Forward) | Upgrade |
Financials | |
Revenue (5 Year Growth) | Upgrade |
Revenue (Quarterly YoY Growth) | Upgrade |
EPS Diluted (5 Year Growth) | Upgrade |
EPS Diluted (Quarterly YoY Growth) | Upgrade |
Debt to Equity Ratio | 0.2638 |
Return on Equity | Upgrade |
Return on Assets | Upgrade |
Risk | |
Beta (5Y) | Upgrade |
Max Drawdown (5Y) | -- |
Profile
Uni-Bio Science Group Ltd is an investment holding company. It operates in three segments: Chemical pharmaceutical products, Biological pharmaceutical products, and Pipeline products. Its geographical segments are Hong Kong and China, of which all of its revenue comes from China. The company products include GeneSoft, GeneTime, Pinup, Boshutai, Bokangtai, and others. All of the company revenue is generated from PRC. |
URL | https://www.uni-bioscience.com |
Investor Relations URL | N/A |
HQ State/Province | N/A |
Sector | Health Care |
Industry | Biotechnology |
Equity Style | Small Cap/Blend |
Next Earnings Release | N/A |
Last Earnings Release | N/A |
Next Ex-Dividend Date | N/A |
Last Ex-Dividend Date | N/A |
Ratings
Profile
Uni-Bio Science Group Ltd is an investment holding company. It operates in three segments: Chemical pharmaceutical products, Biological pharmaceutical products, and Pipeline products. Its geographical segments are Hong Kong and China, of which all of its revenue comes from China. The company products include GeneSoft, GeneTime, Pinup, Boshutai, Bokangtai, and others. All of the company revenue is generated from PRC. |
URL | https://www.uni-bioscience.com |
Investor Relations URL | N/A |
HQ State/Province | N/A |
Sector | Health Care |
Industry | Biotechnology |
Equity Style | Small Cap/Blend |
Next Earnings Release | N/A |
Last Earnings Release | N/A |
Next Ex-Dividend Date | N/A |
Last Ex-Dividend Date | N/A |